Abstract
In male spontaneously hypertensive rats (SHRSP) of the stroke prone strain (Okamoto) and in normotensive Wistar-Kyoto rats (WKY) urinary kallikrein excretion was investigated at different age and at drug-induced diuresis.
In rats of both strains from 7th till 19th week of age urinary kallikrein excretion increased with age. In SHRSP of 7th till 11th week of age kallikrein excretion was higher than in WKY rats, while it was lower in the 48-week-old SHRSP. No correlation was found between urinary kallikrein excretion and systolic blood pressure.
In SHRSP and WKY rats a similar daily rhythm of kallikrein excretion in urine was found being high in the early morning and low in the afternoon. Kallikrein excretion correlated significantly with urine volume.
The loop diuretic bumetanide (4 and 40 mg/kg) induced diuresis and natriuresis in both strains, however more marked in the WKY rats than in the SHRSP. Urinary kallikrein excretion, however, showed in both strains the same biphasic course with a short lasting increase and a secondary decrease. Thus, in the average urinary kallikrein excretion was not effected by the drug.
Prolonged treatment with furosemide over 5 days (125 mg/kg) resulted in an increase in kallikrein excretion in urine, more pronounced in the WKY rats than in the SHRSP.
The observed results suggest that renal kallikrein-kinin system is not involved in the development of spontaneous hypertension as a pathogenetic factor, but rather is influenced by other factors like hormone interactions, i.e. mineralocorticoids and catecholamines, as well as renal function and acute changes in urine flow.
Similar content being viewed by others
References
K. Abe, M. Seino, M. Yasujima, S. Chiba, Y. Sakurai, N. Irokawa, S. Miyazaki, K. Saito, T. Ito, Y. Otsuka andK. Yoshinaga,Studies on renomedullary prostaglandin and renal kallikreinkinin system in hypertension, Jap. Circul. J.41, 873–880 (1977).
A. Lechi, G. Covi, C. Lechi, A. Cornagti, E. Arosio, M. Zatti andL.A. Scuro,Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism, Clin. Sci. Mol. Med.55, 51–55 (1978).
H.S. Margolius, R. Geller, J.J. Pisano andA. Sjoerdsma,Altered urinary kallikrein excretion in human hypertension, Lancetii, 1063–1065 (1971).
K. Okamoto, Y. Yamori andA. Nagaoka,Establishment of the stroke-prone spontaneously hypertensive rat, Circ. Res.34/35 (Suppl. I), 143–153 (1974).
R.G. Geller, H.S. Margolius, J.J. Pisano andH.R. Keiser,Urinary kallikrein excretion in spontaneously hypertensive rats, Circ. Res.36/37 (Suppl. I), 103–106 (1975).
S. Favaro, B. Baggio, A. Antonello, A. Zen, G. Cannella, S. Todesco andA. Borsatti,Renal kallikrein content of spontaneously hypertensive rats, Clin. Sci. Mol. Med.49, 69–71 (1975).
G. Porcelli, B. Bianchi andH.R. Croxatto,Urinary kallikrein excretion in a spontaneously hypertensive strain of rats (38939), Proc. Soc. exp. Biol. Med.149, 983–986 (1975).
O.A. Carretero, A.G. Scicli, A. Piwonska andJ. Koch,Urinary kallikrein in rats bred for susceptibility and resistance to the hypertensive effect of salt and in New Zealdn genetically hypertensive rats, Mayo Clin. Proc.52, 465–467 (1977).
E. Arrigoni-Martelli andChr.K. Nielsen,Urinary kallikrein excretion in normotensive and spontaneously hypertensive rats, Acta pharmac. tox.37, 177–184 (1975).
O.A. Carretero, C. Polomski, A. Hampton andA.G. Scicli,Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats, Clin. Exp. Pharmac. Physiol. Suppl. 3, 55–59 (1976).
Chr.K. Nielsen andE. Arrigoni-Martelli,Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine, Acta pharmac. tox.40, 267–272 (1977).
M. Stocker andJ. Hornung,Application of bradykinin radioimmunoassay for the measurement of urinary kallikrein activity in rats, Klin. Wschr.56 (Suppl. I), 127–129 (1978).
G. Bönner andM. Martin-Grez,Measurement of kallikrein activity in urine of rats and man using a chromogenic tripeptide substrate, J. Biochem. clin. Biochem.19, 165–168 (1981).
J.F.E. Mann, A.K. Johnson andD. Ganten,Plasma angiotensin II: Dipsogenic levels and angiotensin-generating capacity of renin, Am. J. Physiol.238, R 372-R 37 (1980).
A. Schömig, R. Dietz, W. Rascher, J.B. Lüth, J.F.E. Mann, M. Schmidt andJ. Weber,Sympathetic vascular tone in spontaneously hypertensive rats, Klin. Wschr.56 (Suppl. I), 131–138 (1978).
S. Barton, E.J. Sanders, M. Schachter andM. Uddin,Autonomic nerve stimulation, kallikrein content and acinar cell granules of the cat's submandibular gland, J. Physiol.251, 363–369 (1975).
T.B. Ørstavik andK.M. Gautvik,Regulation of salivary kallikrein secretion in the rat submandibular gland, Acta physiol. scand.100, 33–44 (1977).
T. Kudo, Y. Kotani, M. Oka, K. Matsumoto andR. Inoki,Significance of adrenergic α-effect on salivary kallikrein secretion in the submandibular gland of the dog, Adv. exp. Med. Biol.120A, 425–437 (1979).
A. Röckel, H. Zenglein, A. Preissler, J. Völker, G. Hein andA. Heidland,Pharmacological influences on parotid salivary kallikrein concentration in rats. Kidney international20, 161 (1981).
I.H. Mills andL.F.O. Obika,The natriuretic actions of intraarterial acetylcholine and isoprenaline are associated with increased kallikrein excretion in the dog, J. Physiol.289, 37P-38P (1979).
U.B. Olsen,Changes of urinary kallikrein and kinin excretions induced by adrenalin infusion in conscious dogs, Scand. J. clin. Lab. Invest.40, 173–178 (1980).
R. Albertini, R. Ladrón de Guevara, F. Asenjo andM. Boric,Effect of renal nerve stimulation on urine and tissue kininogenase activity in cats, Hypertension3 (Suppl. II), 50–54 (1981).
W. Rascher, G. Bönner, M. Stocker andF. Gross,Increased kallikrein excretion in spontaneously hypertensive rats and its inhibition by 6-hydroxydopamine, Naunyn-Schmiedebergs Arch. Pharmak.313, 155–157 (1980).
B. Bönner, D. Beck, M. Deeg, M. Marin-Grez, U. Schwertschlag andF. Gross,Interrelation between renal kallikrein and diuresis in rats, Adv. exp. Med. Biol.B, 949–960 (1983).
G. Bönner, D. Beck, M. Deeg, M. Marin-Grez andF. Gross,Effects of furosemide on the renal kallikrein-kinin system of the rat, Clin. Sci.63, 447–453 (1982).
H.S. Margolius, D. Horwitz, R.G. Geller, R.W. Alexander, J.R. Gill Jr., J.J. Pisano andH.R. Keiser,Urinary kallikrein excretion in normal man. Relationship to sodium intake and sodium-retaining steriods, Circ. Res.35, 812–819 (1974).
A. Mimran, G. Baudin, D. Casellas andD. Soutas,Urinary kallikrein and changes in endogenous aldosterone in the rat, Eur. J. clin. Invest.7, 497–502 (1977).
G. Bönner, W. Rascher, M. Marin-Grez, B. Rastetter andF. Gross, Urinary kallikrein activity in rats with renovascular hypertension. InHypertension: Mechanism and Management, pp. 163–168 (EdsD. Distler andTh. Philipp), Springer-Verlag Heidelberg 1980.
H.R. Croxatto andM. San Martin,Kallikreinlike activity in the urine of renal hypertensive rats, Experientia26, 1216–1217 (1970).
C.P. Vio, J.S. Roblero andH.R. Croxatto,Kallikrein-kinin and renin-angiotensin systems in renovascular hypertension in rats (40794), Proc. Soc. exp. Biol. Med.163, 447–451 (1980).
H.S. Margolius, R. Geller, W. De Jong, J.J. Pisano andA. Sjoerdsma,Altered urinary kallikrein excretion in rats with hypertension, Circ. Res.30, 358–362 (1972).
W.H. Hörl andA. Heidland,Inactivation of urinary kallikrein by alpha 1 -antitrypsin, Klin. Wschr.59, 761–763 (1981).
D.L. Sustarsic, R.P. McPartland andJ.P. Rapp,Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats, Hypertension2, 813–820 (1980).
Author information
Authors and Affiliations
Additional information
Herrn Professor Dr. med. W. Kaufmann zum 60. Geburtstag
Rights and permissions
About this article
Cite this article
Bönner, G., Unger, T., Rascher, W. et al. The renal kallikrein-kinin system in spontaneously hypertensive rats. Agents and Actions 15, 111–118 (1984). https://doi.org/10.1007/BF01972335
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01972335